Evidence map›Paper›PMID 34838890›Full record

Trial reportRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2022

The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial.

Cindy S Ortiz, Diana Hernández, Cesar Trujillo, David Calderón, Placido Esqueda, Flavio Calva, Arcadio Betancourt, Miriam Ramírez, Graciela Cervantes, Miguel A Souto and 3 more

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Radiotherapy for non-cancer diseases: benefits and long-term risks.International journal of radiation biology · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Cindy S OrtizRadiation Oncology Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Diana HernándezInternal Medicine Department, UMAE 1, Speciality Hospital, Bajio NationalMedical Center, Instituto Mexicano del Seguro Social, Mexico.
Cesar TrujilloInternal Medicine Department, UMAE 1, Speciality Hospital, Bajio NationalMedical Center, Instituto Mexicano del Seguro Social, Mexico.
David CalderónRadiation Oncology Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Placido EsquedaRadiation Oncology Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Flavio CalvaMedical Physics Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Arcadio BetancourtMedical Physics Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Miriam RamírezRadiation Oncology Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Graciela CervantesRadiation Oncology Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Miguel A SoutoRadiation Oncology Department, UMAE 25, Speciality Hospital, Instituto Mexicano del Seguro Social, Mexico.
Juan G CelisDirection, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Luis R NolazcoDirection, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico.
Alejandro OlmosRadiation Oncology Department, UMAE 1, Speciality Hospital, Bajio National Medical Center, Instituto Mexicano del Seguro Social, Mexico. Electronic address: alex_olmos13@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a paired prospective comparative cohort study with 58 patients, in order to analyze the clinical LD-WLI in patients with moderate or severe COVID19 pneumonia. The results of this study show that the Radiotherapy could be an option to improve the clinical response for patients with COVID-19.

Indexed as

COVID-19Cohort StudiesHumansLungProspective StudiesSARS-CoV-2Treatment OutcomeAcute respiratory distress syndrome (ARDS)COVID-19Low dose radiotherapy (LDRT)SARS-CoV2

Identifiers

PMID34838890
PMCPMC8613980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.